Literature DB >> 2635741

Pharmacokinetic evaluation of stable piecewise cubic polynomials as numerical integration functions.

K C Yeh1, R D Small.   

Abstract

A numerical integration method based on piecewise cubic polynomial for computing the area under the curve in pharmacokinetics is presented. The method has been found to produce stable and monotone interpolations irrespective of experimental error. Spurious oscillations occasionally associated with cubic splines are eliminated. Comparisons with the previously available methods suggest that more reliable and less biased areas under the plasma concentration curve, AUC, or areas under the first moment of plasma curve, AUMC, can be generated by the present method.

Entities:  

Mesh:

Year:  1989        PMID: 2635741     DOI: 10.1007/bf01062126

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  16 in total

1.  Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

2.  Kinetic parameter estimation by numerical algorithms and multiple linear regression: theoretical.

Authors:  K C Yeh
Journal:  J Pharm Sci       Date:  1977-12       Impact factor: 3.534

3.  Curve fitting by spline and Akima methods: possibility of interpolation error and its suppression.

Authors:  J Fried; S Zietz
Journal:  Phys Med Biol       Date:  1973-07       Impact factor: 3.609

4.  New method for calculating the intrinsic absorption rate of drugs.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

5.  Pharmacokinetic absorption plots from oral data alone or oral/intravenous data and an exact Loo-Riegelman equation.

Authors:  J G Wagner
Journal:  J Pharm Sci       Date:  1983-07       Impact factor: 3.534

6.  Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

Authors:  D Perrier; M Mayersohn
Journal:  J Pharm Sci       Date:  1982-03       Impact factor: 3.534

7.  Wagner's exact Loo-Riegelman equation: the need for a criterion to choose between the linear and logarithmic trapezoidal rule.

Authors:  J H Proost
Journal:  J Pharm Sci       Date:  1985-07       Impact factor: 3.534

8.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

9.  Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

10.  Kinetic parameter estimation by numerical algorithms and multiple linear regression: application to pharmacokinetics.

Authors:  K C Yeh; K C Kwan
Journal:  J Pharm Sci       Date:  1979-09       Impact factor: 3.534

View more
  11 in total

1.  Variability of the model-independent AUC: the one sample per individual case.

Authors:  W Jawień
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

2.  An extended point-area deconvolution approach for assessing drug input rates.

Authors:  K C Yeh; D J Holder; G A Winchell; L A Wenning; T Prueksaritanont
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

3.  Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC).

Authors:  R D Purves
Journal:  J Pharmacokinet Biopharm       Date:  1992-06

4.  The relevance of residence time theory to pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  On continuity of integration methods for AUC. A note.

Authors:  W Jawień
Journal:  J Pharmacokinet Biopharm       Date:  1998-02

6.  Pharmacokinetic profile and tolerability of indinavir-ritonavir combinations in healthy volunteers.

Authors:  A J Saah; G A Winchell; M L Nessly; M A Seniuk; R R Rhodes; P J Deutsch
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

7.  Coadministration of indinavir and nelfinavir in human immunodeficiency virus type 1-infected adults: safety, pharmacokinetics, and antiretroviral activity.

Authors:  Sharon A Riddler; Diane Havlir; Kathleen E Squires; Brad Kerr; Ronald H Lewis; Kuang Yeh; Linda Hawe Wynne; Ling Zhong; Yahong Peng; Paul Deutsch; Alfred Saah
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

8.  Pharmacokinetics of famotidine in infants.

Authors:  Larissa A Wenning; M Gail Murphy; Laura P James; Jeffrey L Blumer; James D Marshall; John Baier; Ann O Scheimann; Deborah L Panebianco; Ling Zhong; Roy Eisenhandler; Kuang C Yeh; Gregory L Kearns
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

9.  Effect of fluconazole on indinavir pharmacokinetics in human immunodeficiency virus-infected patients.

Authors:  S De Wit; M Debier; M De Smet; J McCrea; J Stone; A Carides; C Matthews; P Deutsch; N Clumeck
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

10.  Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.

Authors:  David W Haas; Benjamin Johnson; Janet Nicotera; Vicki L Bailey; Victoria L Harris; Farideh B Bowles; Stephen Raffanti; Jennifer Schranz; Tyler S Finn; Alfred J Saah; Julie Stone
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.